If the E2F1-mediated distinct regulation of the ARF and TAp73 tumor suppressor genes applies to cell types other than fibroblasts, it is expected that the dysfunction of pRB in conjunction with the dysfunction of p53 will generate and sustain distinct E2F1 activity in cancer cells. This evidence concerns the gene TP53 and cancer.